A bill that would assist in the customization of schedule II quantity limits across the various medical practices was pulled down Wednesday from the Senate Public Health Committee.
Senate Bill 302 would “require licensing boards that govern healthcare practitioners with schedule II prescription authority to adopt rules for mandatory Prescription Drug Monitoring Program checks; authorizes board to place prescription quantity limits.”
The bill, sponsored by Senator Missy Irvin and Representative Justin Boyd, would allow licensing boards the ability to set the quantity rules for their physicians. They proposed that a blanket bill may restrict some physicians from treating their patient in the proper manner. Examples included patients undergoing various types of surgeries may require a different quantity of schedule II narcotics than another patient with a different type of surgery.
Bill sponsors suggested that the bill is a refinement and continuation of the Prescription Drug Monitoring Program and physicians and licensing boards would still have to be up to standard with the Arkansas State Medical Board.
Some did say that 18 states currently have a similar legislation in place. However, they were concerned that the bill did not have a mandate on schedule III narcotics.
Irvin did suggest that the bill addresses the issue of “not one size fits all.”